We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TOST:NYSEToast, Inc. Analysis

Data as of 2026-09-01 - not real-time

$34.08

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Toast, Inc. is bullish at $34.08, with short-term averages leading the long-term ones. Over a rolling month the price has gained 12.2%. Relative strength is 49.9 — neutral — and the MACD signal is bearish. Price has been bracketed by support at $33.22 and resistance at $37.20.
Valuation screens as overvalued: a P/E of 43.1 sits above the sector average of 35.3. Sell-side targets cluster 14.5% above the current quote. Revenue is growing at 23.1% on a 7.1% profit margin.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 41.4%, a beta of 1.05 and a maximum drawdown of 49.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

Toast Inc TOST delivers record 9,500 net new locations and raises full-year guidance as AI-powered products and new...Restaurant technology platform Toast NYSE:TOST announced in Q2 CY2026, with sales up 23.Yahoo Finance27dToast, Inc. TOST Q2 FY2026 earnings call transcriptToast delivered a strong Q2 2026, with recurring...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 30.14
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 43.1 versus sector average of 35.3
  • Trading above the 200-day average of 30.14

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 43.1 versus sector average of 35.3
  • Analyst targets imply +14.5% versus the current price
  • Revenue growth of +23.1%

Key Metrics & Analysis

Financial Health

Revenue Growth23.10%
Profit Margin7.14%
P/E Ratio43.1
ROE25.16%
ROA8.95%
P/B Ratio9.9
Op. Cash Flow$635.0M
Free Cash Flow$474.2M
Industry P/E35.3

Technical Analysis

TrendBullish
RSI49.9
Support$33.22
Resistance$37.20
MA 20$35.20
MA 50$31.86
MA 200$30.14
MACDBearish
VolumeDecreasing
Fear & Greed Index93.84

Valuation

Fair Value$29.50
Target Price$39.04
Upside/Downside14.55%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.05
Volatility41.36%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.